Lexogen, a Vienna-based biotech company specialized in RNA transcriptomics technologies and services announces the completion ...
PeproMene Bio, Inc., a clinical-stage biotechnology company developing novel therapies for relapsed and refractory (r/r) B-cell ...
FutureHouse, an Eric Schmidt-backed nonprofit that aims to build an “AI scientist” within the next decade, has released a new tool that it claims can help support “data-driven discovery” in biology.
EvE Bio, a focused research organization (FRO) supported by Convergent Research and dedicated to systematically mapping the human pharmome - the full network of functional drug?target interactions - ...
CAMBRIDGE, Mass., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune ...
SAN DIEGO--(BUSINESS WIRE)--Rejuvenate Bio, today announced new preclinical efficacy data for RJB-0402, a gene therapy targeting key disease-mediating pathways. RJB-0402 demonstrated efficacy in a ...
CAMBRIDGE, England--(BUSINESS WIRE)--CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), today announced its ...
LA JOLLA, CA, March 17, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell ...
SAb Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback